Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience-Reference-Cited by-同舟云学术

Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience

Published:2023-10 Issue: Volume:217 Page:107348
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Portacci Andrea^ORCID,Iorillo Ilaria,Quaranta Vitaliano Nicola,Maselli Leonardo,Lulaj Ernesto,Buonamico Enrico,Dragonieri Silvano^ORCID,Carpagnano Giovanna Elisiana

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur. Respir. J.,2014

2. Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis;Edris;Respir. Res.,2019

3. Defining a severe asthma super-responder: findings from a Delphi process;Upham;J. Allergy Clin. Immunol. Pract.,2021

4. Super-Responders to biologic treatment in type 2-high severe asthma: passing fad or a meaningful phenotype?;Portacci;J. Allergy Clin. Immunol. Pract.,2023

5. An expert consensus framework for asthma remission as a treatment goal;Menzies-Gow;J. Allergy Clin. Immunol.,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab responder types and predicting factors in patients with type 2 severe asthma: A real-world cohort study;Respiratory Medicine;2024-09

2. Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma;Allergology International;2024-09

3. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial;Journal of Allergy and Clinical Immunology;2024-06

4. Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma;Journal of Asthma;2024-04-04

5. Remission in asthma;Current Opinion in Pulmonary Medicine;2024-03-05